Nano spray drying technique as a novel approach to formulate stable econazole nitrate nanosuspension formulations for ocular use

Molecular Pharmaceutics

Volumn 13, Issue 9, 2016, Pages 2951-2965

  Maged, Amr ^a   Mahmoud, Azza A ^a,b   Ghorab, Mahmoud M ^c  

^a Future University in Egypt   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

eye drops; nano spray dryer; nanoparticles

Indexed keywords

BETA CYCLODEXTRIN; CHITOSAN; CREMOPHOR; DRUG CARRIER; ECONAZOLE; MACROGOL; NANOPARTICLE; POLOXAMER; POLYSORBATE 80; POVIDONE; EYE DROPS; SUSPENSION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; IN VIVO STUDY; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; X RAY DIFFRACTION; ZETA POTENTIAL; ANIMAL; CHEMISTRY; LEPORIDAE; ULTRASTRUCTURE;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG LIBERATION; ECONAZOLE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; RABBITS; SUSPENSIONS; VISCOSITY; X-RAY DIFFRACTION;

EID: 84986252345     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.6b00167     Document Type: Article

References (50)

1. Duchene, D.; Wouessidjewe, D. Pharmaceutical uses of cyclodextrins and derivatives Drug Dev. Ind. Pharm. 1990, 16 (17) 2487-2499 10.3109/03639049009058543
2. Hariprasad, S. et al. Voriconazole in the treatment of fungal eye infections: a review of current literature Br. J. Ophthalmol. 2008, 92 (7) 871-878 10.1136/bjo.2007.136515
3. Martini, F.; Ober, W. C. Fundamentals of Anatomy & Physiology; Pearson Benjamin Cummings: San Francisco, CA, 2006; pp 557-562.
4. Al-Marzouqi, A. H. et al. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques J. Pharm. Biomed. Anal. 2009, 49 (2) 227-233 10.1016/j.jpba.2008.10.032
5. Patravale, V. B.; Date, A. A.; Kulkarni, R. M. Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 2004, 56 (7) 827-40 10.1211/0022357023691
6. Nogueiras-Nieto, L.; Delgado-Charro, M. B.; Otero-Espinar, F. J. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine Eur. J. Pharm. Biopharm. 2013, 83 (3) 370-377 10.1016/j.ejpb.2012.11.004
7. Keck, C. M.; Müller, R. H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 2006, 62 (1) 3-16 10.1016/j.ejpb.2005.05.009
8. Singh, S. K. et al. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide Eur. J. Pharm. Biopharm. 2011, 78 (3) 441-446 10.1016/j.ejpb.2011.03.014
9. Moinard-Checot, D. et al. Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process J. Nanosci. Nanotechnol. 2006, 6 (9-10) 2664-2681 10.1166/jnn.2006.479
10. Li, X. et al. Nanoparticles by spray drying using innovative new technology: The Büchi Nano Spray Dryer B-90 J. Controlled Release 2010, 147 (2) 304-310 10.1016/j.jconrel.2010.07.113
11. Harsha, S. Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization Drug Des., Dev. Ther. 2013, 7, 1027 10.2147/DDDT.S39956
12. Schafroth, N. et al. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process Colloids Surf., B 2012, 90, 8-15 10.1016/j.colsurfb.2011.09.038
13. Marques, M. R.; Loebenberg, R.; Almukainzi, M. Simulated biological fluids with possible application in dissolution testing Dissolution Technol. 2011, 18 (3) 15-28 10.14227/DT180311P15
14. Khan, K. A.; Rhodes, C. T. Effect of compaction pressure on the dissolution efficiency of some direct compression systems Pharm. Acta Helv. 1972, 47 (10) 594-607
15. Mahmoud, A. A. et al. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery Int. J. Pharm. 2011, 413 (1) 229-236 10.1016/j.ijpharm.2011.04.031
16. De Campos, A. M. et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity Pharm. Res. 2004, 21 (5) 803-810 10.1023/B:PHAM.0000026432.75781.cb
17. Draize, J. H.; Woodard, G.; Calvery, H. O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes J. Pharmcol. Exp. Ther. 1944, 82 (3) 377-390
18. Liu, Z. et al. Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes J. Pharm. Pharmacol. 2006, 58 (1) 45-50 10.1211/jpp.58.1.0006
19. Ng, T. et al. Rapid high performance liquid chromatographic assay for antifungal agents in human sera J. Antimicrob. Chemother. 1996, 37 (3) 465-472 10.1093/jac/37.3.465
20. Patravale, V. B.; Date, A. A.; Kulkarni, R. M. J. Pharm. Pharmacol. 2004, 56 (7) 827-840 10.1211/0022357023691
21. Verma, S.; Huey, B. D.; Burgess, D. J. Scanning probe microscopy method for nanosuspension stabilizer selection Langmuir 2009, 25 (21) 12481-7 10.1021/la9016432
22. Ribeiro, L. S. S.; Ferreira, D. C.; Veiga, F. J. B. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state Eur. J. Pharm. Sci. 2003, 20 (3) 253-266 10.1016/S0928-0987(03)00199-4
23. Sahoo, S. K.; Dilnawaz, F.; Krishnakumar, S. Nanotechnology in ocular drug delivery Drug Discovery Today 2008, 13 (3) 144-151 10.1016/j.drudis.2007.10.021
24. Charoenchaitrakool, M.; Dehghani, F.; Foster, N. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin Int. J. Pharm. 2002, 239 (1) 103-112 10.1016/S0378-5173(02)00078-9
25. Palla, B.; Shah, D. Stabilization of high ionic strength slurries using surfactant mixtures: molecular factors that determine optimal stability J. Colloid Interface Sci. 2002, 256 (1) 143-152 10.1006/jcis.2002.8648
26. Kocbek, P.; Baumgartner, S.; Kristl, J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs Int. J. Pharm. 2006, 312 (1) 179-186 10.1016/j.ijpharm.2006.01.008
27. Haj-Ahmad, R. R. et al. Compare and contrast the effects of surfactants (Pluronic® F-127 and Cremophor® EL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme Eur. J. Pharm. Sci. 2013, 49 (4) 519-534 10.1016/j.ejps.2013.05.004
28. Ko, M. K. et al. Characterization of the adsorption-fouling layer using globular proteins on ultrafiltration membranes J. Membr. Sci. 1993, 76 (2) 101-120 10.1016/0376-7388(93)85210-N
29. Kumar, S.; Burgess, D. J. Nanosuspensions. In Long Acting Injections and Implants; Burgess, D. J.; Wright, J. C., Eds.; Springer: New York, 2012; pp 239-261.
30. Müller, R.; Jacobs, C.; Kayser, O. Nanosuspensions for the formulation of poorly soluble drugs. In Pharmaceutical Emulsion and Suspension; Müller, R.; Jacobs, C.; Kayser, O., Eds.; Marcel Dekker; New York, 2000; pp 383-407.
31. Ain-Ai, A.; Gupta, P. K. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound Int. J. Pharm. 2008, 351 (1) 282-288 10.1016/j.ijpharm.2007.09.029
32. Helgason, T. et al. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN) J. Colloid Interface Sci. 2009, 334 (1) 75-81 10.1016/j.jcis.2009.03.012
33. Verma, S.; Gokhale, R.; Burgess, D. J. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 2009, 380 (1) 216-222 10.1016/j.ijpharm.2009.07.005
34. Lindfors, L. et al. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening Langmuir 2006, 22 (3) 906-910 10.1021/la0523661
35. Choi, J. Y. et al. Role of polymeric stabilizers for drug nanocrystal dispersions Curr. Appl. Phys. 2005, 5 (5) 472-474 10.1016/j.cap.2005.01.012
36. Jiang, J.; Oberdörster, G.; Biswas, P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies J. Nanopart. Res. 2009, 11 (1) 77-89 10.1007/s11051-008-9446-4
37. Thienpont, D. et al. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic Arzneim.-Forsch. 1975, 25 (2) 224-230
38. Pedersen, M. et al. An econazole β-cyclodextrin inclusion complex: an unusual dissolution rate, supersaturation, and biological efficacy example Int. J. Pharm. 1998, 165 (1) 57-68 10.1016/S0378-5173(97)00431-6
39. Maggi, L. et al. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug Biomaterials 2002, 23 (4) 1113-1119 10.1016/S0142-9612(01)00223-X
40. Mosharraf, M.; Nyström, C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs Int. J. Pharm. 1995, 122 (1) 35-47 10.1016/0378-5173(95)00033-F
41. Bertram, U.; Bodmeier, R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form Eur. J. Pharm. Sci. 2006, 27 (1) 62-71 10.1016/j.ejps.2005.08.005
42. Zhang, L. et al. Development and in-vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur J. Controlled Release 2002, 85 (1) 73-81 10.1016/S0168-3659(02)00273-0
43. Dolenc, A. et al. Advantages of celecoxib nanosuspension formulation and transformation into tablets Int. J. Pharm. 2009, 376 (1) 204-212 10.1016/j.ijpharm.2009.04.038
44. Bilensoy, E. et al. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex AAPS PharmSciTech 2006, 7 (2) 54-6 10.1208/pt070238
45. Pattnaik, S. et al. Effect of casting solvent on crystallinity of ondansetron in transdermal films Int. J. Pharm. 2011, 406 (1-2) 106-10 10.1016/j.ijpharm.2011.01.009
46. Repka, M. A. et al. Characterization of cellulosic hot-melt extruded films containing lidocaine Eur. J. Pharm. Biopharm. 2005, 59 (1) 189-96 10.1016/j.ejpb.2004.06.008
47. Felt, O. et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention Int. J. Pharm. 1999, 180 (2) 185-193 10.1016/S0378-5173(99)00003-4
48. Huacai, G.; Wan, P.; Dengke, L. Graft copolymerization of chitosan with acrylic acid under microwave irradiation and its water absorbency Carbohydr. Polym. 2006, 66 (3) 372-378 10.1016/j.carbpol.2006.03.017
49. Mura, P. et al. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties Eur. J. Pharm. Sci. 2003, 19 (1) 67-75 10.1016/S0928-0987(03)00068-X
50. Zhou, H. Y. et al. Nanoparticles in the ocular drug delivery Int. J. Opthalmol 2013, 6 (3) 390-396